China Resources Shuanghe: Controlling subsidiary Xiangzhong Pharmaceutical's Okaysipine tablets obtained drug registration certificate.

China Resources Shuanghe announced that its holding subsidiary Xiangzhong Pharmaceutical has received the Drug Registration Certificate for Oxclozapine Tablets issued by the National Medical Products Administration.